BLFS vs BMY · rev $56.0M vs P/E 17, rev $24.46B
BioLife Solutions Inc (BLFS) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
BioLife Solutions Inc (BLFS) is a medical instruments & supplies company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Latest reported BLFS revenue for 2026-06-30 was $56.0M. Net income was $46.3M. BLFS currently screens at market cap $1.05B.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BLFS currently screens at market cap $1.05B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the BLFS and BMY stock pages for the full models.
Not investment advice.